| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.4B | $40.6B | $34.1B | $32.0B | $27.8B | $19.4B | $4.3B | $4.7B |
| Cost of Revenue | $39.5B | $34.4B | $28.7B | $27.2B | $23.7B | — | — | — |
| Gross Profit | — | — | — | — | — | $2.5B | $0.6B | $0.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.8B | $1.7B | $1.6B | $1.2B | $1.0B | $1.1B | $1.0B | $1.1B |
| Net Income | $0.5B | $1.2B | $1.1B | $0.8B | $0.7B | $0.7B | $0.2B | $0.2B |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $2.70 | $3.24 |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $2.67 | $3.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.6B | $15.6B | $14.9B | $12.3B | $12.2B | $9.5B | $6.8B | $7.2B |
| Current Assets | $12.4B | $12.8B | $12.5B | $10.1B | $10.1B | $7.9B | $6.0B | $6.5B |
| Cash & Equivalents | $4.2B | $4.7B | $4.8B | $4.0B | $4.4B | $4.2B | $2.5B | $2.8B |
| Total Liabilities | $11.5B | $11.1B | $10.7B | $9.3B | $9.6B | $7.4B | $4.8B | $5.5B |
| Current Liabilities | $7.4B | $7.9B | $8.2B | $6.9B | $7.0B | $5.0B | $3.3B | $4.2B |
| Stockholders' Equity | $4.1B | $4.5B | $4.2B | $3.0B | $2.6B | $2.1B | $2.0B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.5B | $0.6B | $1.7B | $0.8B | $2.1B | $1.9B | $0.4B | $-0.3B |
| Investing Cash Flow | $0.3B | $-0.5B | $-0.7B | $-0.8B | $-1.7B | $-0.4B | $-0.3B | $1.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.3B | $-0.1B | $-0.4B | $-0.2B | $0.2B | $-0.6B | $-1.2B |